Groups join the Biosimilars Council and AAM letter of support for interchangeability legislation
39 Groups support the Biosimilar Red Tape Elimination Act.
The Biosimilars Council
Report: A decade of biosimilars and barriers remain
Matrix Global Advisors report highlights current barriers and recommendations for robust competition and patient savings in the next decade.